Last reviewed · How we verify
Iron supplement C
Iron supplement C replenishes iron stores to treat or prevent iron deficiency anemia by providing bioavailable iron for hemoglobin synthesis.
Iron supplement C replenishes iron stores to treat or prevent iron deficiency anemia by providing bioavailable iron for hemoglobin synthesis. Used for Iron deficiency anemia, Iron supplementation in iron-deficient patients.
At a glance
| Generic name | Iron supplement C |
|---|---|
| Sponsor | Tanabe Pharma Corporation |
| Drug class | Iron supplement |
| Target | Iron (Fe2+/Fe3+) |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
Iron is an essential mineral required for the formation of hemoglobin and myoglobin, which transport and store oxygen in the blood and muscles. Iron supplement C delivers iron in a form designed for gastrointestinal absorption to restore depleted iron stores and normalize red blood cell production. This corrects the underlying iron deficiency that causes anemia and associated symptoms like fatigue and weakness.
Approved indications
- Iron deficiency anemia
- Iron supplementation in iron-deficient patients
Common side effects
- Gastrointestinal upset (nausea, constipation, abdominal discomfort)
- Dark stools
- Abdominal pain
- Diarrhea
Key clinical trials
- Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.
- Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy (NA)
- Chemo Brain Prehab Project (NA)
- Effects of Iron Supplements on the Pharmacokinetics of MT-6548 (PHASE3)
- Dietary Strategy to Tackle Sarcopenia in Early Elderly Subjects (FOOP-Sarc) (NA)
- Evaluation of the Effect of FertyBiotic Pregnancy in the Metabolic Profile in Pregnant Women (NA)
- Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years) (NA)
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iron supplement C CI brief — competitive landscape report
- Iron supplement C updates RSS · CI watch RSS
- Tanabe Pharma Corporation portfolio CI